|
1
|
Lodato F, Mazzella G, Festi D, Azzaroli F,
Colecchia A and Roda E: Hepatocellular carcinoma prevention: a
worldwide emergence between the opulence of developed countries and
the economic constraints of developing nations. World J
Gastroenterol. 12:7239–7249. 2006.
|
|
2
|
El-Serag HB: Epidemiology of
hepatocellular carcinoma. Clin Liver Dis. 5:87–107. 2001.
View Article : Google Scholar
|
|
3
|
Goodgame B, Shaheen NJ, Galanko J and
El-Serag HB: The risk of end stage liver disease and hepatocellular
carcinoma among persons infected with hepatitis C virus:
publication bias? Am J Gastroenterol. 98:2535–2342. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simonetti RG, Cammà C, Fiorello F, Politi
F, D’Amico G and Pagliaro L: Hepatocellular carcinoma: a worldwide
problem and the major risk factors. Dig Dis Sci. 36:962–972. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J: Oleanolic acid and ursolic acid:
research perspectives. J Ethnopharmacol. 100:92–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu YL, Kuo PL and Lin CC: Proliferative
inhibition, cell-cycle dysregulation, and induction of apoptosis by
ursolic acid in human non-small cell lung cancer A549 cells. Life
Sci. 75:2303–2316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi BM, Park R, Pae HO, et al: Cyclic
adenosine monophosphate inhibits ursolic acid-induced apoptosis via
activation of protein kinase A in human leukaemic HL-60 cells.
Pharmacol Toxicol. 86:53–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi YH, Baek JH, Yoo MA, et al: Induction
of apoptosis by ursolic acid through activation of caspases and
down-regulation of c-IAPs in human prostate epithelial cells. Int J
Oncol. 17:565–571. 2000.PubMed/NCBI
|
|
10
|
Huang MT, Ho CT, Wang ZY, et al:
Inhibition of skin tumorigenesis by rosemary and its constituents
carnosol and ursolic acid. Cancer Res. 54:701–708. 1994.PubMed/NCBI
|
|
11
|
Nishino H, Nishino A, Takayasu J, et al:
Inhibition of the tumor-promoting action of
12-O-tetradecanoylphorbol-13-acetate by some oleanane-type
triterpenoid compounds. Cancer Res. 48:5210–5215. 1988.PubMed/NCBI
|
|
12
|
Cha HJ, Bae SK, Lee HY, et al:
Anti-invasive activity of ursolic acid correlates with the reduced
expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human
fibrosarcoma cells. Cancer Res. 56:2281–2284. 1996.PubMed/NCBI
|
|
{
label needed for ref[@id='b13-mmr-09-06-2505']
}
|
[13] Saxelin ML,
Nurmiaho-Lassila EL, Meriläinen VT and Forsén RI: Ultrastructure
and host specificty of bacteriophages of Streptococcus
cremoris, Streptococcus lactis subsp diacetylactis, and
Leuconostoc cremoris from Finnish fermented milk ‘viili’.
Appl Environ Microbiol. 52:771–777. 1986.PubMed/NCBI
|
|
14
|
Liu L, Wu J, Zhang J, et al: A
compatibility assay of ursolic acid and foodborne microbial
exopolysaccharides by antioxidant power and anti-proliferative
properties in hepatocarcinoma cells. J Food Agric Environ.
10:111–114. 2012.
|
|
15
|
Kitazawa H, Yamaguchi T and Itoh T: B-cell
mitogenic activity of slime products produced from slime-forming,
encapsulated Lactococcus lactis ssp cremoris. J Dairy Sci.
75:2946–2951. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shao BM, Xu W, Dai H, et al: A study on
the immune receptors for polysaccharides from the roots of
Astragalus membranaceus, a Chinese medicinal herb. Biochem
Biophys Res Commun. 320:1103–1111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ross R: Atherosclerosis - an inflammatory
disease. N Eng J Med. 340:115–126. 1999. View Article : Google Scholar
|
|
18
|
Akhtar M, Cheng Y, Magno RM, et al:
Promoter methylation regulates Helicobacter
pylori-stimulated cyclooxygenase-2 expression in gastric
epithelial cells. Cancer Res. 61:2399–2403. 2001.
|
|
19
|
Kim H, Lim JW and Kim KH: Helicobacter
pylori-induced expression of interleukin-8 and cyclooxygenase-2
in AGS gastric epithelial cells: mediation by NF-kappaB. Scand J
Gastroenterol. 36:706–716. 2001.
|
|
20
|
Shariat SF, Kim JH, Ayala GE, et al:
Cyclooxygenase-2 is highly expressed in carcinoma in situ
and T1 transitional cell carcinoma of the bladder. J Urol.
169:938–942. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leng J, Han C, Demetris AJ, et al:
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth
through Akt activation: evidence for Akt inhibition in
celecoxib-induced apoptosis. Hepatology. 38:756–768. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baek JY, Hur W, Wang JS, et al: Selective
COX-2 inhibitor, NS-398, suppresses cellular proliferation in human
hepatocellular carcinoma cell lines via cell cycle arrest. World J
Gastroenterol. 13:1175–1181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
24
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oztürk HS, Karayvaz M, Kaçmaz M, et al:
Activities of the enzymes participating in purine and free-radical
metabolism in cancerous human colorectal tissues. Cancer Biochem
Biophs. 16:157–168. 1998.PubMed/NCBI
|
|
26
|
Eapen CE, Madesh M, Balasubramanian KA, et
al: Mucosal mitochondirial function and antioxidation defences in
patients with gastric carcinoma. Scand J Gastroenterol. 33:975–981.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo C, Urgard E, Vooder T and Metspalu A:
The role of COX-2 and Nrf2/ARE in anti-inflammation and
antioxidative stress: Ageing and anti-ageing. Med Hypotheses.
77:174–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen C: COX-2’s new role in inflammation.
Nat Chem Biol. 6:401–402. 2010.
|
|
29
|
Groeger AL, Cipollina C, Cole MP, Woodcock
SR, et al: Cyclooxygenase-2 generates anti-inflammatory mediators
from omega-3 fatty acids. Nat Chem Biol. 6:433–441. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kerr JF, Winterford CM and Harmon BV:
Apoptosis. Its significance in cancer and cancer therapy. Cancer.
73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elstein KH and Zucker RM: Comparison of
cellular and nuclear flow-cytometric techniques for discriminating
apoptotic subpopulations. Exp Cell Res. 211:322–331. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lebeer S, Claes IJ, Verhoeven TL, et al:
Exopolysaccharides of Lactobacillus rhamnosus GG form a
protective shield against innateimmune factors in the intestine.
Microb Biotechnol. 4:368–374. 2011.
|
|
33
|
Goodman MT, Wu AH, Tung KH, et al:
Association of dairy products, lactose, and calcium with the risk
of ovarian cancer. Am J Epidemiol. 156:148–157. 2002. View Article : Google Scholar : PubMed/NCBI
|
